Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
6.82
+1.61 (30.90%)
Jan 22, 2025, 2:25 PM EST - Market open
Nutriband Employees
Nutriband had 13 employees as of January 31, 2022. The number of employees increased by 8 or 160.00% compared to the previous year.
Employees
13
Change (1Y)
8
Growth (1Y)
160.00%
Revenue / Employee
$155,521
Profits / Employee
-$526,703
Market Cap
75.74M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
NTRB News
- 22 days ago - Nutriband Issues Letter to Shareholders - GlobeNewsWire
- 26 days ago - Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology - GlobeNewsWire
- 7 weeks ago - Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - GlobeNewsWire
- 2 months ago - Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology - GlobeNewsWire
- 2 months ago - Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application - Accesswire
- 3 months ago - Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - Accesswire
- 4 months ago - Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 - Accesswire
- 4 months ago - Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology - Accesswire